442 related articles for article (PubMed ID: 18538862)
1. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
[TBL] [Abstract][Full Text] [Related]
2. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
3. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
Gras S; Saulquin X; Reiser JB; Debeaupuis E; Echasserieau K; Kissenpfennig A; Legoux F; Chouquet A; Le Gorrec M; Machillot P; Neveu B; Thielens N; Malissen B; Bonneville M; Housset D
J Immunol; 2009 Jul; 183(1):430-7. PubMed ID: 19542454
[TBL] [Abstract][Full Text] [Related]
4. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
[TBL] [Abstract][Full Text] [Related]
5. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
Nastke MD; Herrgen L; Walter S; Wernet D; Rammensee HG; Stevanović S
Cell Mol Life Sci; 2005 Jan; 62(1):77-86. PubMed ID: 15619009
[TBL] [Abstract][Full Text] [Related]
6. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
[TBL] [Abstract][Full Text] [Related]
7. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
[TBL] [Abstract][Full Text] [Related]
8. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of human cytomegalovirus-specific cytotoxic T cells by recombinant polyepitope: implications for HCMV immunotherapy.
Rist M; Cooper L; Elkington R; Walker S; Fazou C; Tellam J; Crough T; Khanna R
Eur J Immunol; 2005 Mar; 35(3):996-1007. PubMed ID: 15726667
[TBL] [Abstract][Full Text] [Related]
10. Ad-gBCMVpoly: A novel chimeric vaccine strategy for human cytomegalovirus-associated diseases.
Zhong J; Khanna R
J Clin Virol; 2009 Dec; 46 Suppl 4():S68-72. PubMed ID: 19646921
[TBL] [Abstract][Full Text] [Related]
11. Bacterial surface proteins recognized by CD4+ T cells during murine infection with Listeria monocytogenes.
Campbell DJ; Shastri N
J Immunol; 1998 Sep; 161(5):2339-47. PubMed ID: 9725229
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
13. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
Lo-Man R; Martineau P; Hofnung M; Leclerc C
Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
[TBL] [Abstract][Full Text] [Related]
15. Progress made towards the development of a CMV peptide vaccine.
Paston SJ; Dodi IA; Madrigal JA
Hum Immunol; 2004 May; 65(5):544-9. PubMed ID: 15172455
[TBL] [Abstract][Full Text] [Related]
16. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
Davies JK; Koh MB; Lowdell MW
Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
[TBL] [Abstract][Full Text] [Related]
17. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
[TBL] [Abstract][Full Text] [Related]
18. Recognition of CMV pp65 protein antigen by human CD4 T-cell lines induced with an immunodominant peptide pool.
Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Bracci L; Lozzi L; Scarso L; Tripodi G; Manca F
Hum Immunol; 2004 May; 65(5):537-43. PubMed ID: 15172454
[TBL] [Abstract][Full Text] [Related]
19. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.
Peacey M; Wilson S; Baird MA; Ward VK
Biotechnol Bioeng; 2007 Dec; 98(5):968-77. PubMed ID: 17546687
[TBL] [Abstract][Full Text] [Related]
20. Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.
Suneetha PV; Schlaphoff V; Wang C; Stegmann KA; Fytili P; Sarin SK; Manns MP; Cornberg M; Wedemeyer H
J Immunol Methods; 2009 Mar; 342(1-2):33-48. PubMed ID: 19135447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]